Synergy of LCL161, an antagonist of inhibitor of apoptosis proteins (IAPs), with paclitaxel in a gene expression signature-enriched cohort of triple-negative breast cancer (TNBC)
Data de publicación
2015Título da revista
EUROPEAN JOURNAL OF CANCER
Tipo de contido
Publicación de congreso